The CPFF receives a number of inquiries from international PF patients around the world who want to get access to Esbriet, where it has not yet been approved in their country – as patients want to know if it can be prescribed for them in Canada.
The University Health Network, through Toronto General Hospital, has an International Patient Service that can be accessed here https://www.uhn.ca/IHP/International_Patients